Silence Therapeutics Plc ADR (XRP2)
FSX
Closed
Oct 20, 2026
Day's Range
17.0052 wk Range
3.40Overview - XRP2 - Silence Therapeutics Plc ADR
Key Statistics
Valuation
Enterprise Value
276.04M
P/E (Trailing)
‪-4.28‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪818.61‬
Price / Book
‪11.15‬
EV / EBITDA
‪-4.86‬
Profitability
Profit Margin
‪61.53%‬
Operating Margin
‪-10,475.61%‬
Return on Assets
‪-29.64%‬
Return on Equity
‪-90.40%‬
Ownership
Shares Outstanding
141.73M
Float
37.85M
Held by Insiders
‪7.96%‬
Held by Institutions
‪49.31%‬
Price stats
Beta
‪1.44‬
50-Day Avg
‪10.67‬
200-Day Avg
‪7.04‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - XRP2 - Silence Therapeutics Plc ADR
Peers - XRP2 - Silence Therapeutics Plc ADR
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- XRP2FSXSilence Therapeutics Plc ADR503.44MMarket Cap+33.95%52-week change-4.29P/E (Trailing)‪61.53%‬Profit Margin
- ANLFSXAnalog Devices Inc.173.23BMarket Cap+42.13%52-week change49.48P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.75.83BMarket Cap+88.13%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 1AEFSXargenx SE46.38BMarket Cap+7.13%52-week change36.55P/E (Trailing)‪32.26%‬Profit Margin
- 64BFSXAstera Labs, Inc.45.97BMarket Cap+48.68%52-week change176.19P/E (Trailing)‪30.74%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt45.90BMarket Cap-5.00%52-week change32.46P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.36.20BMarket Cap+75.13%52-week change-28.39P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - XRP2 - Silence Therapeutics Plc ADR
About
Silence Therapeutics Plc ADR is a biotechnology company focused on developing RNA-based medicines that use short interfering RNA, or siRNA, to regulate the activity of specific genes. Silence Therapeutics Plc ADR is working across hematology, cardiovascular disease, and rare diseases, with a pipeline that includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
